Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment is important for better hair regrowth in elderly women with hair loss.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

The document concludes with the creation of a Hair Transplant Foundation after reviewing the early hair transplant techniques and discussions from a forum.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Female pattern baldness may indicate a higher risk of coronary artery disease.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

An ovarian tumor can cause high male hormones in postmenopausal women.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

Certain gene changes and hormone levels are linked to female hair loss.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.